GLTO
Q3 2026 EPS Estimate
$-0.45
Aug 5, 2026

Analyst Sentiment

Wall St. Consensus
Buy
5 analysts·Limited coverage
65
Score
3 Buy (60%)2 Hold (40%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
360%
Hold
240%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$40.00
+85.4%
Consensus
$42.50
+96.9%
Bull
$45.00
+108.5%
12-Month Target Range5 analysts
$40.00$42.50$45.00
Current $21.58Consensus
Current Price
$21.58
Upside to Consensus
$20.92

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev
EPS
FY2028
Rev+258.67%
EPS
FY2029
Rev
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$22M$77M
Low$22M$77M
High$22M$77M
EBITDA Avg
Low
High
EBIT Avg
Low
High
Net Income Avg$-2M$-2M$-3M$-4M
Low$-2M$-3M$-4M$-4M
High$-2M$-1M$-2M$-4M
EPS Avg$-1.07$-1.48$-2.09$-2.53
Low$-1.07$-2.13$-2.58$-2.53
High$-1.07$-0.92$-1.60$-2.53
Analysts (Rev / EPS) / 22 / 32 / 2 / 1
Quarterly
MetricQ3 2026Q4 2026
Revenue Avg
Low
High
EBITDA Avg
Low
High
EBIT Avg
Low
High
Net Income Avg$-472,711$-505,807
Low$-472,711$-505,807
High$-472,711$-505,807
EPS Avg$-0.30$-0.32
Low$-0.30$-0.32
High$-0.30$-0.32
Analysts (Rev / EPS) / 1 / 1

Earnings Surprises

Recent Analyst Actions

Feb 17, 2026UBS
Galecto initiated with a Buy at UBS
Target:$45.00
+47.6%from $30.50
Feb 17, 2026Guggenheim
Galecto price target raised to $40 from $36 at Guggenheim
Target:$40.00
+37.4%from $29.12
Jan 7, 2026Leerink Partners
Galecto initiated with an Outperform at Leerink
Target:$46.00
+110.6%from $21.84
Dec 8, 2025Guggenheim
Galecto price target raised to $36 from $32 at Guggenheim
Target:$36.00
+40.0%from $25.72
Dec 1, 2025Guggenheim
Galecto initiated with a Buy at Guggenheim
Target:$32.00
+80.0%from $17.78
Oct 17, 2024Oppenheimer
Galecto (GLTO) PT Raised to $10 at Oppenheimer
Target:$10.00
+49.0%from $6.71
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.